Veracyte, Inc.

VCYT Nasdaq SEC CIK 1384101
Follow Veracyte Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $151.8M +15.1% vs same quarter last year
Net income $31.5M +64.6% vs same quarter last year
EPS, diluted $0.38 +58.3% vs same quarter last year
Operating cash flow $40.3M −10.1% vs same quarter last year
Revenue by quarter
$118.6M
$114.5M
$130.2M
$131.9M
$140.6M
$139.1M
$150.3M
$151.8M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M$0$200M$400M$600MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$517.1M$66.4M
FY24$445.8M$24.1M
FY23$361.1M−$74.4M
FY22$296.5M−$36.6M
FY21$219.5M−$75.6M
FY20$117.5M−$34.9M
FY19$120.4M−$12.6M
FY18$92M−$23M
FY17$72M−$31M
FY16$65.1M−$31.4M
FY15$49.5M−$33.7M
FY14$38.2M−$29.4M
FY13$21.9M−$25.6M
FY12$11.6M−$18.6M
FY11$2.6M−$14.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2570.1%11.2%12.8%
FY2466.9%3.6%5.4%
FY2363.6%−23.8%−20.6%
FY2259.2%−13.9%−12.3%
FY21-−37.3%−34.4%
FY20-−30.1%−29.7%
FY1970%−12.6%−10.5%
FY1864%−24.2%−25%
FY1760.8%−36.9%−43.1%
FY1660.9%−44.3%−48.2%
FY1556.6%−67.6%−68.1%
FY1456.5%−76%−76.9%
FY1342.4%−105.9%−116.9%
FY1234.8%−162.8%−160.4%
FY11−10.6%−577.2%−546.1%
Free cash flowOperating cash flow minus capital expenditure
−$50M$0$50M$100M$150MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$126.6M
FY24$63.8M
FY23$34.3M
FY22−$1M
FY21−$37M
FY20−$12.5M
FY19−$6M
FY18−$15.4M
FY17−$25.7M
FY16−$32.2M
FY15−$33.1M
FY14−$29.7M
FY13−$20.5M
FY12−$8.6M
FY11−$13.8M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Veracyte
  • Healthcare median
−600%−400%−200%0%200%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearVeracyteHealthcare median
FY2512.8%−30.6%
FY245.4%−47.3%
FY23−20.6%−58%
FY22−12.3%−80.4%
FY21−34.4%−71.8%
FY20−29.7%−61.5%
FY19−10.5%−46%
FY18−25%−49.6%
FY17−43.1%−45.9%
FY16−48.2%−36%
FY15−68.1%−37.8%
FY14−76.9%−35.5%
FY13−116.9%−37.1%
FY12−160.4%−29.1%
FY11−546.1%−27.9%